Skip to content

Ventricular Arrhythmia After Myocarditis in Sportsman

Quantification of Ventricular Arrhythmia After Myocarditis in Sportsman

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03842592
Acronym
ARYMYS
Enrollment
50
Registered
2019-02-15
Start date
2019-11-06
Completion date
2028-02-01
Last updated
2026-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocarditis Acute, Ventricular Arrythmia

Brief summary

The study aims to assess the prevalence of ventricular rhythmic disorder after an acute myocarditis in sportsmen. 50 patients with acute myocarditis, confirmed by MRI, will be assessed by ECG Holter and Treadmill stress test during a 1-year follow-up.

Interventions

DIAGNOSTIC_TESTTreadmill Stress test

Ventricular arrhythmia will be assessed by ECG Holter and during treadmill stress test, both being performed 3 months and 1 year after acute myocarditis

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* acute myocarditis, diagnosed on the association of (a) recent viral infection (upper airway, gastro-intestinal) , (b) troponin increase, and (c) chest pain AND myocarditis confirmed by cardiac magnetic resonance 2 out of 3 Lake Louise criteria, either T2 hypersignal, early enhancement or late gadolinium enhancement. * regular physical activity, recreational or competitive: \>=4 hours weekly * written informed consent

Exclusion criteria

* coronary artery disease * acute inflammatory cardiomyopathy (sarcoidosis, fulminant myocarditis, Tako Tsubo, eosinophilic myocarditis, Lyme disease) * history of myocarditis * contra-indication to cardiac MRI * patient unable to perform a treadmill stress test

Design outcomes

Primary

MeasureTime frameDescription
Complex ventricular arrhythmiaany timepoint: 3 month and/or 1 yearany ventricular tachycardia (triplet or more), ventricular fibrillation (observed on ECG Holter or during stress test)

Secondary

MeasureTime frameDescription
In-hospital ventricular arrhythmiaup to 2 weeks after admissionany ventricular tachycardia (triplet or more), ventricular fibrillation, recorded on ECG monitoring
Left Ventricular remodelingbetween baseline and 3 monthsChange in LV volumes during time
Left ventricular fibrosisbetween baseline and 3 monthsChange in interstitial fibrosis by T1 mapping cardiac magnetic resonnance
Major adverse cardio vascular eventup to 2 years after inclusionCV death, sudden cardiac death, cardiac graft or haemodynamic support, hospitalisation for heart failure, new event of myocarditis
return to physical activityup to 2 years after inclusiondefined as at least 75% of exercising time (in hours per week)

Countries

France

Contacts

PRINCIPAL_INVESTIGATORLoïc BIERE, MD PhD

Department of Cardiology, University Hospital of Angers (France)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026